Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose-dependent Insulinotropic Polypeptide (GIP)
- Target
- GIP
- Molecular classification
- Peptide Hormone, Incretin, Secretin Family
01
Overview
Glucose-dependent insulinotropic polypeptide (GIP), also known as gastric inhibitory polypeptide, is a 42-amino acid peptide hormone that acts as an incretin. It stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also modulates glucagon secretion and promotes adipogenesis. GIP exerts pleiotropic effects beyond glycemic control including promoting growth and survival of pancreatic beta-cells, influencing brain function, bone metabolism, cardiovascular system regulation, and gastrointestinal tract physiology. Targeting the GIP-GIPR axis is being investigated for treating type 2 diabetes mellitus (T2DM) and obesity.
- Other names
- Gastric Inhibitory Polypeptide
02
Mechanism of action
Stimulates insulin release from pancreatic beta cells in a glucose-dependent manner; modulates glucagon secretion; promotes fat deposition in adipose tissue.
03
Biological functions
Stimulates insulin secretionModulates glucagon secretionPromotes adipogenesisPromotes beta-cell growth and survivalReduces beta-cell apoptosisInfluences brain functionInfluences bone metabolismCardiovascular system regulationGastrointestinal tract physiology
04
Disease associations
Type 2 Diabetes MellitusObesity
05
Safety considerations
Potential for excessive adipogenesisPotential for hypoglycemia with GIPR agonists
06
Interacting drugs
DPP-IV inhibitors
3 more in the full profile.
07
Biomarkers
GIP levels
Beyond the preview
Go deeper on Glucose-dependent Insulinotropic Polypeptide (GIP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glucose-dependent Insulinotropic Polypeptide (GIP).